Effects of L-carnitine on mechanical recovery of isolated rat hearts in relation to the perfusion with glucose and palmitate

Molecular and Cellular Biochemistry

Volumn 185, Issue 1-2, 1998, Pages 65-75

  Löster, Heinz ^a   Punzel, Michael ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Carnitine; Ischemia; Langendorff hearts; Long chain acylcarnitines; Reperfusion

Indexed keywords

CARNITINE; FATTY ACID; GLUCOSE; PALMITIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; ISOLATED HEART; NONHUMAN; RAT;

ANIMALS; CARNITINE; FATTY ACIDS; FEMALE; GLUCOSE; HEART; MYOCARDIAL REPERFUSION; MYOCARDIUM; PALMITIC ACID; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0031656818     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006891208220     Document Type: Article

References (51)

1. Lopaschuk GD, Saddik M: The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol Cell Biochem 116 (1-2): 111-116, 1992
2. Liedtke AJ, De Maison L, Eggleston AM, Cohen LM, Nellis SH: Changes in substrate metabolism and of excess fatty acids in reperfused myocardium. Circ Res 62: 535-562, 1988
3. Duan J, Karmazyn M: Effect of D,L-carnitine on the response of the isolated heart of the rat to ischaemia and reperfusion: Relation to mitochondrial function. Br J Pharmacol 98: 1319-1327, 1989
4. Gürtler A-K, Löster H: Carnitin und seine Bedeutung bei der Pathogenese und Therapie der Herz- und Kreislauferkrankungen, Ponte Press, Bochum, 1996, 116 pp
5. Katz KM, Messineo FC: Lipid membrane interactions and the pathogenesis of ischemic damage in myocardium. Circ Res 48: 1-16, 1981
6. Lopaschuk GD, Wall SR, Olley PM, Davies NJ: Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res 63: 1036-1043, 1988
7. Opie LH: Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 97: 375-388, 1979
8. Paulson DJ, Shug AL: Inhibition of the adenine nucleotide translocator by matrix-localized palmityl-CoA in rat heart mitochondria. Biochim Biophys Acta 766: 70-76, 1984
9. Paulson DJ, Traxler J, Schmidt M, Noonan J, Shug AL: Protection of the ischaemic myocardium by L-propionylcarnitine: Effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 20: 536-541, 1986
10. Broderick TL, Quinney HA, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working heart. J Biol Chem 267: 8162-8170, 1992
11. Lopaschuk GD, McNeill, McVeigh JJ : Glucose oxidation is stimulated in reperfused hearts with the carnitine palmitoyltransferase I inhibitor, Etomoxir. Mol Cell Biochem 188: 175-179, 1989
12. Lopaschuk GD, Spafford MA, Davies NJ, Wall RS: Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 6: 546-553, 1990
13. Stanlay WC, Lopaschuk GD, Hall JL, McCormack JG: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33: 243-257, 1997
14. De Jong JW, Ferrari R (eds): The carnitine system: A new therapeutical approach to cardiovascular diseases, Kluwer Academic Publishers, Dordrecht, Boston, London, 1995, pp 393
15. Ferrari R, Dimauro S, Sherwood G (eds): L-carnitine and its role in medicine: From function to therapy, Academic Press London, San Diego, New York, Boston, Sydney, Tokyo, Toronto, 1992, pp433
16. Shug AL, Thomsen JH, Folts JD, Bittar N, Klein MI, Koke JR, Huth PJ: Changes in tissue levels of carnitine and other metabolises during myocardial ischemia and anoxia. Arch Biochem Biophys 187: 25-33, 1978
17. Broderick TL, Quinney HA, Barker C, Lopaschuk GD: Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after transient period of global ischemia is accompanied by stimulation of glucose oxidation. Circ 87: 972-981, 1993
18. Kotaka K, Miyazaki Y, Ogawa K, Satake T, Kitazawa M, Sugiyama S, Ozawa T: Protective effects of carnitine and its derivatives against free fatty acid-induced mitochondrial dysfunction. J Appl Biochem 3: 328-336, 1981
19. Liedtke AJ, Nellis SH, Copenhaver G: Effects of carnitine in ischemic and fatty acid supplemented swine hearts. J Clin Invest 64: 440-447, 1979
20. Liedtke AJ, Nellis SH, Whitesell LF: Effects of carnitine isomers on fatty acid metabolism in ischemic swine hearts. Circ Res 48: 859-866, 1981
21. Liedtke AJ, Nellis SH, Whitesell LF, Mahar CQ: Metabolic and mechanical effects using L- and D-carnitine in working swine hearts. Am J Physiol 243: H691-H697, 1982
22. Liedtke AJ, Vary TC, Nellis SH, Fultz CW: Properties of carnitine incorporation in working swine hearts. Effects of coronary flow, ischemia, and excess fatty acids. Circ Res 50: 767-774, 1982
23. Neely JR, Garber D, McDonough K, Idell-Wenger J: Relationship between ventricular function and intermediates of fatty acid metabolism during myocardial ischemia: Effects of carnitine. In: Ischemic Myocardium and Antianginal Drugs, Raven Press, New York, 1979, pp 225-234
24. Silverman NA, Schmitt G, Vishwanath M, Feinberg H, Levitzky S: Effect of carnitine on myocardial function and metabolism following global ischemia. Ann Thorac Surg 40: 20-24, 1985
25. Suzuki Y, Kamikawa T, Kobayashi A, Masamura Y, Yamazaki N: Effects of L-carnitine on tissue levels of acyl carnitine, acyl coenzyme A and high energy phosphate in ischemic dog hearts. Jpn Cire J 45: 687-694, 1981
26. Gmeiner R, Apstein CS, Brachfeld N: Effect of palmitate on hypoxic cardiac performance. J Mol Cell Cardiol 7: 227-235, 1975
27. Paulson DJ, Schmidt MJ, Romens J, Shug AL: Metabolic and physiological differences between zero-flow and low-flow ischemia: Effects of L-acetylcarnitine. Basic Res Cardiol 79: 551-561, 1984
28. Vik-Mo H, Mjos OD: Influence of free fatty acids on myocardial oxygen consumption in intact dogs. Am J Cardiol 48: 361-365, 1981
29. Ichihara K, Neely JR: Recovery of ventricular function in reperfused ischemic rat hearts exposed to fatty acids. Am J Physiol 249: H492-H497, 1985
30. Da Torre SD, Creer MH, Pogwizd SM, Corr PB: Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J Mol Cell Cardiol 23 (Suppl. 1): 11-22, 1991
31. Heathers GP, Su C-M, Adames VR, Higgins AJ: Reperfusion-induced accumulation of long-chain acylcarnitines in previously ischemic myocardium. J Cardiovasc Pharmacol 22: 857-862, 1993
32. Lopaschuk GD, Warmbolt RB, Barr RL: An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144, 1993
33. Mickle DAG, Del Nido PJ, Wilson GJ, Harding RD, Romaschin AD: Exogenous substrate preference of the postischemic myocardium. Cardiovasc Res 20: 256-263, 1986
34. Renström B, Liedtke JA, Nellis SH: Mechanisms of substrate preference for oxidative metabolism during early myocardial reperfusion. Am J Physiol 259: H317-H323, 1990
35. Van der Vusse GJ, Glatz JFC, Stam HCG, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Phys Rev 72: 881-940, 1992
36. Abdel-aleem S, Nada MA, Sayed-Ahmed M, Hendrickson SC, St-Louis J, Walthall HP, Löwe JE: Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes. J Mol Cell Cardiol 28: 825-833, 1996
37. Finegan BA, Clanachan AS, Coulson CS, Lopaschuk GD: Adenosine modification of energy substrate use in isolated hearts perfused with fatty acids. Am J Physiol 262: H1501-H1507, 1992
38. Hearse DJ, Shattock MJ, Manning AS, Braimbridge MV: Protection of the myocardium during ischemic arrest: Possible toxicity of carnitine in cardioplegic solutions. Thorac Cardiovasc Surg 28: 253-258, 1980
39. Paulson DJ, Schmidt MJ, Traxler JS, Ramacci MT, Shug AL: Improvement of myocardial function in diabetic rats after treatment with L-carnitine. Metabolism 33: 358-363, 1984
40. Paulson DJ, Shug AL: Effects of carnitine on the ischemic arrested heart. Basic Res Cardiol 77: 460-463, 1982
41. Idell-Wenger JA, Grotyohann LW, Neely JR: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310-4318, 1978
42. Ferrari R, Ciampalini G, Agnoletti G, Cargnoni A, Ceconi C, Visioli O: Effect of L-carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation. Pharmacol Res Commun 20: 125-132, 1988
43. Subramanian R, Plehn S, Noonan J, Schmidt M, Shug AL: Free radical-mediated damage during myocardial ischemia and reperfusion and protection by carnitine esters. Z Kardiol 76 (Suppl. 5): 41-45, 1987
44. Davies NJ, Schulz R, Olley PM, Strynadka KD, Panas DL, Lopaschuk GD: Lysoplasmentylethanolamine accumulation in ischemic/reperfused isolated fatty acid-perfused hearts. Circ Res 70: 1161-1168, 1992
45. Piper HM, Das A: Detrimental actions of endogenous fatty acids and their derivatives. A study of ischemic mitochondrial injury. Bas Res Cardiol 82 (Suppl. 1): 187-196, 1987
46. Van Bilsen M, Van der Vusse GJ, Willemsen PH, Coumans WA, Reneman RS: Fatty acid accumulation during ischemia and reperfusion: Effects of pyruvate and POCA, a carnitine palmitoyltransferase I inhibitor. J Mol Cell Cardiol 23: 1437-1447, 1991
47. Van der Vusse GJ, Prinzen FW, Van Bilsen M, Engels W, Reneman RS: Accumulation of lipids and lipid-intermediates in the heart during ischemia. Basic Res Cardiol 82: 157-167, 1987
48. Nagao B, Kobayashi A, Yamazaki N: Effects of L-carnitine on phospholipids in the ischemic myocardium. Jpn Heart J 28: 243-251, 1987
49. Saddik M, Lopaschuk GD: Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem 267: 3825-3831, 1992
50. Ronca G, Ronca F, Yu G, Zucchi R, Bertelli A: Protection of isolated perfused working rat hearts from oxidative stress by exogenous L-propionyl carnitine. Drugs Exp Clin Res 18 (11-12): 475-480, 1992
51. Packer L, Valenza M, Serbinova E, Starke-Reed P, Frost K, Kagan V: Free radical scavenging is involved in the protective effect of L-Propionyl carnitine against ischemia reperfusion injury of the heart. Arch Biochem Biophys 288: 533-537, 1991